Bladder cancer (BC) has a typical aetiology characterized by a multistep carcinogenesis due to environmental exposures, genetic susceptibility, and their interaction. Several lines of evidence suggest that DNA repair plays a role in the development and progression of BC. In particular, the study of individual susceptibility to DNA double strand breaks (DSBs) may provide valuable information on BC risk, and help to identify those patients at high-risk of either recurrence or progression of the disease, possibly personalizing both surveillance and treatment. Among the different DSB markers, the most well characterized is phosphorylation of the histone H2AX (γ-H2AX). We assessed any potential role of γ-H2AX as a molecular biomarker in a case-control study (146 cases and 146 controls) to identify individuals with increased BC risk and at high-risk of disease recurrence or progression. We investigated γ-H2AX levels in peripheral blood mononuclear cells before and after their exposure to ionizing radiation (IR). We did not find any significant difference among cases and controls. However, we observed a significant association between γ-H2AX basal levels and risk of disease recurrence or progression. In particular, both BC patients as a whole and the subgroup of non-muscle invasive BC (NMIBC) with high basal H2AX phosphorylation levels had a decreased risk of recurrence or progression (for all BC HR 0.70, 95%CI 0.52-0.94, P = 0.02; for NMIBC HR 0.68, 95%CI 0.50-0.92, P = 0.01), suggesting a protective effect of basal DSB signaling. Our data suggest that γ-H2AX can be considered as a potential molecular biomarker to identify patients with a higher risk of BC recurrence. © 2015 Wiley Periodicals, Inc.

H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancer

Turinetto, Valentina
Co-first
;
Pardini, Barbara
Co-first
;
Allione, Alessandra
Co-first
;
Fiorito, Giovanni;Viberti, Clara;Guarrera, Simonetta;Russo, Alessia;Anglesio, Silvia;Ruo Redda, Maria Grazia;Casetta, Giovanni;Oderda, Marco;Gontero, Paolo;Rolle, Luigi;Frea, Bruno;Vineis, Paolo;Sacerdote, Carlotta;Giachino, Claudia;Matullo, Giuseppe
Last
2016-01-01

Abstract

Bladder cancer (BC) has a typical aetiology characterized by a multistep carcinogenesis due to environmental exposures, genetic susceptibility, and their interaction. Several lines of evidence suggest that DNA repair plays a role in the development and progression of BC. In particular, the study of individual susceptibility to DNA double strand breaks (DSBs) may provide valuable information on BC risk, and help to identify those patients at high-risk of either recurrence or progression of the disease, possibly personalizing both surveillance and treatment. Among the different DSB markers, the most well characterized is phosphorylation of the histone H2AX (γ-H2AX). We assessed any potential role of γ-H2AX as a molecular biomarker in a case-control study (146 cases and 146 controls) to identify individuals with increased BC risk and at high-risk of disease recurrence or progression. We investigated γ-H2AX levels in peripheral blood mononuclear cells before and after their exposure to ionizing radiation (IR). We did not find any significant difference among cases and controls. However, we observed a significant association between γ-H2AX basal levels and risk of disease recurrence or progression. In particular, both BC patients as a whole and the subgroup of non-muscle invasive BC (NMIBC) with high basal H2AX phosphorylation levels had a decreased risk of recurrence or progression (for all BC HR 0.70, 95%CI 0.52-0.94, P = 0.02; for NMIBC HR 0.68, 95%CI 0.50-0.92, P = 0.01), suggesting a protective effect of basal DSB signaling. Our data suggest that γ-H2AX can be considered as a potential molecular biomarker to identify patients with a higher risk of BC recurrence. © 2015 Wiley Periodicals, Inc.
2016
55
11
1833
1842
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2744
bladder cancer; event-free survival; H2AX phosphorylation assay; overall survival; peripheral blood mononuclear cells; Molecular Biology; Cancer Research
Turinetto, Valentina; Pardini, Barbara; Allione, Alessandra; Fiorito, Giovanni; Viberti, Clara; Guarrera, Simonetta; Russo, Alessia; Anglesio, Silvia;...espandi
File in questo prodotto:
File Dimensione Formato  
Turinetto et al.pdf

Accesso aperto

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 525.48 kB
Formato Adobe PDF
525.48 kB Adobe PDF Visualizza/Apri
Revised manuscript PDF.pdf

Accesso riservato

Dimensione 617.83 kB
Formato Adobe PDF
617.83 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
2016_Turinetto.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 349.39 kB
Formato Adobe PDF
349.39 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
mc.22431.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 345.05 kB
Formato Adobe PDF
345.05 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1589540
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 12
social impact